Monument Therapeutics

There has been an uptick in investor interest in non-oncology therapy areas in the past couple of years, with neuroscience again becoming a hot area, but biotechs in the space are finding that access

2022 Rising Leaders Thijs Cohen Tervaert Manuela Corti Rosamond Deegan Debora Dumont Giovanna Forte Nethaji Gallage Sarah Gheuens Kiri Granger Elizabeth Jungman Laurie Keefer Tim Knotnerus Therese Lie

Rising Leaders Home Central nervous system disorders represent a huge and growing unmet health need, yet drug development has stalled for some conditions and has not got off the ground at all for oth

Recently spun out from UK-based Cambridge Cognition Holdings plc with 15-months’ worth of working seed capital, CNS-focused Monument Therapeutics is now working to put two repurposed and reformula